MedPath

The use of hyaluronic acid in the treatment of abnormal narrowing of the spinal canal in the lumbar spine

Not Applicable
Completed
Conditions
Patients with pain complaints as a result of lumbar foraminal stenosis
Musculoskeletal Diseases
Registration Number
ISRCTN14155217
Lead Sponsor
Sutherland Medical Center
Brief Summary

2023 Results article in https://doi.org/10.3390/jcm12062359 (added 17/04/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Clinical symptoms of radicular pain in the lumbar region
2. MRI confirmed recital stenosis of degenerative origin
3. No other spine diseases (post-traumatic, systemic inflammatory diseases, cancer, birth defects)
4. Adults consenting to the injection
5. Mental contact ensuring cooperation in the period of neuromobilization

Exclusion Criteria

1. Neurological deficit
2. The presence of other spine diseases (post-traumatic, systemic inflammatory diseases, neoplasms, birth defects)
3. Refusal to consent to the injection
4. Anticoagulants, other injection contraindications
5. Impeded contact with the patient, not promising cooperation during the period of neuromobilization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath